Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Olga Benítez"'
Autor:
Olga Benítez Hidalgo, Maria Fernanda Martinez Garcia, Irene Corrrales Insa, Mariana Fernández‐Caballero, Lorena Ramírez Orihuela, Vicente Cortina Giner, Natàlia Comes Fernández, Juan Carlos Juarez Gimenez
Publikováno v:
eJHaem, Vol 4, Iss 2, Pp 476-482 (2023)
Abstract Introduction: Rare bleeding disorders (RBD) constitute 5% of total hereditary bleeding disorders, although the number could be higher, due to the presence of undiagnosed asymptomatic patients. The objective of this study was to analyze the p
Externí odkaz:
https://doaj.org/article/dc23f968667b4037814c72ce01fefd05
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTStandard FIX prophylaxis for PWHB require frequent injections, which has led to the development of extended half-life products like rIX-FP (albutrepenonacog alfa) that has shown good efficacy in clinical studies. This ambispective study aims
Externí odkaz:
https://doaj.org/article/665a1b2ad7d044f5965a3410638193cf
Autor:
Francisco-José López-Jaime, Olga Benítez, Bolívar Luis Díaz Jordán, Adrián Montaño, Julia Coll, Laura Quintana París, María Del Carmen Gómez-del Castillo Solano
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTIntroduction Prophylaxis with emicizumab, a bispecific monoclonal antibody that mimics FVIII function, has shown encouraging results in clinical trials in terms of efficacy and safety. However, current experience is limited, and many areas of
Externí odkaz:
https://doaj.org/article/1d46b7e37b7449699265910244b59dc3
Autor:
Víctor Jiménez-Yuste MD, PhD, María Teresa Alvarez-Román MD, Ángeles Palomo Bravo MD, Bernardo J. Galmes MD, Maria del Mar Nieto Hernández MD, Olga Benítez Hidalgo MD, Cristina Marzo Alonso MD, Noelia Florencia Pérez González MD, Julia Coll MD, Ramiro Núñez MD, Marina Carrasco MD, Faustino García Candel MD, Jose Ramon Gonzalez-Porras MD, Carmen Hernández García MD, Maria José Varó Castro MD, Roser Mir PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Objective To evaluate the efficacy and safety of a plasma-derived factor VIII concentrate containing von Willebrand Factor (pdVWF/FVIII) in standard clinical practice in von Willebrand Disease (VWD) patients. Methods A retrospective, multicentric, ob
Externí odkaz:
https://doaj.org/article/5d0e1875ee074ffdbdd01dcdf3329a79
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maria Teresa Pagliari, Ulrich Budde, Luciano Baronciani, Peyman Eshghi, Minoo Ahmadinejad, Zahra Badiee, Mohammad-Reza Baghaipour, Olga Benítez Hidalgo, Eugenia Biguzzi, Imre Bodó, Giancarlo Castaman, Jenny Goudemand, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W.G. Leebeek, Maria Fernanda Lopez Fernandez, Renato Marino, Johannes Oldenburg, Ian Peake, Cristina Santoro, Reinhard Schneppenheim, Andreas Tiede, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Hamideh Yadegari, Eva M.K. Zetterberg, Pier Mannuccio Mannucci, Augusto B. Federici, Jeroen Eikenboom, Flora Peyvandi
Publikováno v:
Journal of Thrombosis and Haemostasis, 21(4), 787-799. Wiley-Blackwell Publishing Ltd
Background: Type 3 von Willebrand disease (VWD) is the most severe form of this disease owing to the almost complete deficiency of von Willebrand factor (VWF). Replacement therapy with plasma-derived products containing VWF or recombinant VWF rarely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48de6e8d5acdc7bb3ab809bf9a7566de
http://www.scopus.com/inward/record.url?scp=85150944900&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85150944900&partnerID=8YFLogxK
Autor:
Rocío Ferreiro-Iglesias, Marta Piqueras, Elena Ricart, Laura Sempere, Mariona Roca, Javier Martín de Carpi, Olga Benítez, Yamile Zabana, Míriam Mañosa, Francisco Rodríguez-Moranta, Manuel Barreiro-de Acosta
Publikováno v:
Gastroenterología y Hepatología (English Edition). 45:805-818
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d74c42430ff33b31be7a3afc9d60c71b
https://doi.org/10.1016/j.gastre.2022.03.004
https://doi.org/10.1016/j.gastre.2022.03.004
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Manuel Barreiro-de, Acosta, Agnès, Fernández-Clotet, Francisco, Mesonero, Francisco Javier, García-Alonso, María José, Casanova, Margarita, Fernández-de la Varga, Fiorella, Cañete, Luisa, de Castro, Ana, Gutiérrez, Beatriz, Sicilia, Victoria, Cano, Olga, Merino, Ruth, de Francisco, Irene, González-Partida, Gerard, Surís, Leyanira, Torrealba, Rocío, Ferreiro-Iglesias, Beatriz, Castro, Lucía, Márquez, Ana, Sobrino, Ainara, Elorza, Xavier, Calvet, Pilar, Varela, Raquel, Vicente, Luis, Bujanda, Laura, Lario, Noemí, Manceñido, Mariana F, García-Sepulcre, Eva, Iglesias, Cristina, Rodríguez, Marta, Piqueras, Juan Ángel, Ferrer Rosique, Alfredo J, Lucendo, Olga, Benítez, Melody, García, David, Olivares, Carlos, González-Muñoza, Beatriz, López-Cauce, Victor Jair, Morales Alvarado, Katerina, Spicakova, Alicia, Brotons, Fernando, Bermejo, Pedro, Almela, Nahia, Ispízua, Pau, Gilabert, Carlos, Tardillo, Fernando, Muñoz, Pablo, Navarro, Rosa Eva, Madrigal Domínguez, Pau, Sendra, Esther, Hinojosa, Empar, Sáinz, María Dolores, Martín-Arranz, Daniel, Carpio, Elena, Ricart, Berta, Caballol, Laura, Núñez, Jesús, Barrio, Javier P, Gisbert, Marisa, Iborra, Margalida, Calafat, Vicent, Hernández, Roser Muñoz, Pérez, José Luis, Cabriada, Eugeni, Domènech, Iago, Rodríguez-Lago
Publikováno v:
American Journal of Gastroenterology.
The prevalence of penetrating complications in Crohn's disease (CD) increases progressively over time, but evidence on the medical treatment in this setting is limited. The aim of this study was to evaluate the effectiveness of biologic agents in CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a409a6928a58741e27977c01d5247196
https://doi.org/10.14309/ajg.0000000000002152
https://doi.org/10.14309/ajg.0000000000002152
Autor:
María E. Mingot‐Castellano, Faustino García‐Candel, Olga Benítez‐Hidalgo, Ana Marco, Gala A. Méndez Navarro, Rocío Pérez‐Montes, Gloria García Donas, Mariana Canaro, María J. Paloma, Beatríz Asenjo, Victoria M. Calle‐Gordo, Noelia P. González, Ramón Rodríguez González, Isabel S. Caparrón‐Miranda, Laura Quintana París, Sonia Herrero, Ramiro Nuñez
[Objective] Activated prothrombin complex concentrate (aPCC) is a bypassing agent indicated to treat bleeds in patients with acquired hemophilia A (AHA). Nevertheless, its efficacy and safety in the real-world setting have not often been addressed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7f160b5b74393310bf9e4233d690074
https://api.elsevier.com/content/abstract/scopus_id/85137753364
https://api.elsevier.com/content/abstract/scopus_id/85137753364
